Hemogenyx Raises Capital via Warrant Exercise
LONDON, U.K., Feb. 23, 2026 — Hemogenyx Pharmaceuticals PLC announced the exercise of warrants and subsequent issue of new...
Cell Therapy
Advertisement
FibroBiologics to Spotlight Cell Therapy at H-SPAN Summit
Houston, Texas — February 10, 2026: FibroBiologics, Inc., a clinical-stage biotechnology company advancing fibroblast-based therapeutics, announced that its Chairman...
AI Drug Discovery Pact Targets Next-Gen Therapies
SAN DIEGO, Calif. & CAMBRIDGE, Mass., Feb. 9, 2026 — Clinical-stage life science technology company Iambic Therapeutics has entered...
Anixa Advances CAR-T Dose Escalation in Ovarian Cancer
SAN JOSE, Calif., Feb. 9, 2026 — Anixa Biosciences reported encouraging survival observations from its ongoing Phase 1 ovarian...
FDA Expands Yescarta Label in CNS Lymphoma Care
Santa Monica, California — February 6, 2026 Kite, a Gilead Company, has announced that the U.S. Food and Drug...
Advertisements
Next-Gen Biopreservation Solutions Advance Cell Therapy
Miami, Florida — February 6, 2026 CaseBioscience® has announced the launch of CaseCryo® CTG DMSO and CaseStor® HSS Hypothermic...
Immusoft Earns FDA Rare Pediatric Disease Status for ISP-002
SAN FRANCISCO, CALIFORNIA | January 26, 2026 — Immusoft, a clinical-stage biotechnology company pioneering engineered B cell therapies, announced...
Artiva Highlights Durable AlloNK Outcomes at 2026 Tandem
San Diego, California, January 21, 2026 — Artiva Biotherapeutics, a clinical-stage biopharmaceutical company focused on allogeneic natural killer (AlloNK)...
FibroBiologics to Present at Global Healthcare Investment Forum
HOUSTON | January 6, 2026 — FibroBiologics, Inc. announced that its Founder and Chief Executive Officer will present at...
Omisirge Delivers Breakthrough Outcomes for Severe Aplastic Anemia
DUBLIN, IRELAND & LONDON, UK — December 8, 2025 — Ayrmid Ltd., parent company of Gamida Cell Inc., announced...
Advertisement
